AVE Science & Technology Co

AVE Science & Technology Co Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of AVE Science & Technology Co (688067.SS) as of Nov 16, 2026 is 143.50 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 98.12 % — a change of 46.26% (higher).

Cash Conversion

143.50 %

YoY

46.26%

Last updated:

Cash Conversion Rate (OCF/Net Income) of AVE Science & Technology Co is 2025 143.50 % . Cash Conversion Rate (OCF/Net Income) of AVE Science & Technology Co was 2024 98.12 % . It decreases by 46.26% higher compared to the previous year.

The AVE Science & Technology Co Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
147.94 CNY
Jan 1, 2019
122.91 CNY
Jan 1, 2020
155.92 CNY
Jan 1, 2021
150.87 CNY
Jan 1, 2022
165.47 CNY
Jan 1, 2023
105.56 CNY
Jan 1, 2024
98.12 CNY
Jan 1, 2025
143.50 CNY
The AVE Science & Technology Co Cash Conversion history
YEARCash ConversionYoY
143.50 %+46.26%
98.12 %-7.05%
105.56 %-36.21%
165.47 %+9.67%
150.87 %-3.24%
155.92 %+26.85%
122.91 %-16.91%
147.94 %+63.54%
90.46 %-12.16%
102.98 %+18.44%
86.95 %-36.43%
136.77 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AVE Science & Technology Co Stock analysis

What does AVE Science & Technology Co do? AVE Science & Technology Co., Ltd. generates revenue through the research, development, production, sale, and service of clinical testing and analysis instruments. Its main products include urine formed component analyzer, urine dry chemistry analyzer, urine full item automatic analyzer, automatic stool analyzer, automatic body fluid analyzer, reproductive tract secretion analyzer, and special supporting in vitro diagnostic reagents and medical consumables. These products are primarily sold to inspection departments within medical and health institutions in both domestic and overseas markets. The company serves healthcare facilities that require diagnostic equipment for laboratory testing and patient care. The firm's product portfolio targets healthcare institutions seeking advanced diagnostic tools for efficient clinical analysis. By focusing on specialized instruments like urine and stool analyzers, AVE Science & Technology addresses specific needs in medical testing departments. The company's domestic and international distribution channels ensure broad market access for its diagnostic solutions. AVE Science & Technology's revenue streams are derived from the sale of its comprehensive range of clinical testing instruments and related consumables. The company's domestic market presence and overseas sales contribute to its overall business performance. Its products support routine diagnostic procedures across various healthcare settings, driving consistent demand for its equipment and reagents. AVE Science & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AVE Science & Technology Co stock

Cash Conversion Rate (OCF/Net Income) of AVE Science & Technology Co is 143.50 % in 2025.

Cash Conversion Rate (OCF/Net Income) of AVE Science & Technology Co changed from 98.12 % to 143.50 %, representing a 46.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) AVE Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s AVE Science & Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — AVE Science & Technology Co

All Key Metrics — AVE Science & Technology Co